Furthermore, gene interactions between cuproptosis regulators (e.g., FDX1, DLAT) and ferroptosis regulators (e.g., GPX4, SLC7A11) emphasize their interaction, highlighting potential therapeutic strategies that target mitochondrial vulnerabilities in cancers (210). Here, GPX4 is linked to cancer.